Amytal

The American Epilepsy Society and the Epilepsy Foundation have learned that Amytal Sodium Injection, an essential drug for administering the WADA test in lateralizing language function prior to brain surgery, is now available to health care professionals. Ranbaxy Pharmaceuticals, the product’s exclusive worldwide manufacturer, has obtained regulatory clearance from the U.S. Food and Drug Administration (FDA) and the U.S. Drug Enforcement Administration (DEA) to begin distribution abroad. Health care professionals needing this product can obtain information by contacting Ranbaxy’s U.S. headquarters.